Results 121 to 130 of about 208,015 (380)
Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers
Background Impaired myocardial blood flow (MBF) in the absence of epicardial coronary disease is a feature of hypertrophic cardiomyopathy (HCM). Although most evident in hypertrophied or scarred segments, reduced MBF can occur in apparently normal segments.
Rebecca K. Hughes+14 more
wiley +1 more source
Background Significant mitral regurgitation in patients undergoing transcatheter aortic valve replacement (TAVR) is associated with increased mortality. The aim of this study is to determine if surgical correction of both aortic and mitral valves in high
Pey-Jen Yu+6 more
doaj +1 more source
D. Muller+17 more
semanticscholar +1 more source
Transcatheter aortic valve replacement in patients with concomitant mitral stenosis
AIMS Multivalvular disease is of increasing concern in elderly patients undergoing transcatheter aortic valve replacement (TAVR). The objective of the present analysis was to investigate the impact of concomitant mitral stenosis (MS) on clinical outcomes
M. Asami+9 more
semanticscholar +1 more source
Clinical impact of tricuspid regurgitation in patients with acute myocardial infarction
Abstract Aims The clinical impact of tricuspid regurgitation (TR) in patients after acute myocardial infarction (AMI) is largely unknown. The aim of this study was to clarify the prevalence and prognostic impact of TR in post‐AMI patients treated with appropriate primary percutaneous coronary intervention (PCI).
Shun Nishino+5 more
wiley +1 more source
Transcatheter mitral valve repair and replacement
Mitral regurgitation is the valvular heart disease with the highest prevalence in the Western countries, and its prevalence increases with age.1 Conventional surgery provides excellent results in the younger population free of comorbidities, but up to 50% of the patients with severe mitral ...
Maisano, Francesco+3 more
openaire +5 more sources
Long-term survival after aortic valve replacement with the Mitroflow bioprosthesis : a comparative study [PDF]
Background Recent case reports of early structural degeneration of the Mitroflow valve have cast doubts on the suitability of this bioprosthesis, particularly in the smaller sizes, and in younger patients.
Camilleri, Liberato, Manche, Alexander
core +1 more source
Abstract Background and aims The pulmonary artery pulsatility index (PAPi), that is, the pulmonary artery pulse pressure (PAPP) divided by the mean right atrial pressure (mRAP), is an increasingly used invasive index of right ventricular function. We sought to assess the prognostic impact of the PAPi in unselected patients with aortic stenosis (AS ...
Laura A. Rechsteiner+9 more
wiley +1 more source
OBJECTIVES Although mitral valve repair is rarely required in neonates, this population is considered to be at high risk for adverse outcomes. The aim of this study was to review the indications for surgery, mechanisms, repair techniques, and mid-term ...
Patrick O. Myers+7 more
doaj +1 more source